A
Adicet Bio
ACET
1.52000
USD
0.02
(1.33%)
مغلق
حجم التداول
6,793
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
104,649,219
الأخبار
العنوان: Adicet Bio
القطاع: Healthcare
الصناعة: Biotechnology
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate,ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.